Clinical trial
Erythropoietin Spinal Cord Compression Randomized Trial
NCT00220675 · Sunnybrook Health Sciences Centre, Other · Terminated
Key facts
| NCT number | NCT00220675 |
|---|---|
| Title | Erythropoietin Spinal Cord Compression Randomized Trial |
| Official title | Recombinant Human Erythropoietin (r-HuEPO) in the Prevention of Neurologic Sequelae From Malignant Spinal Cord Compression: a Multi-Center, Placebo-Controlled, Phase 2 Randomized Study |
| Lead sponsor | Sunnybrook Health Sciences Centre, Other |
| Collaborators | Ortho Biotech, Inc. Industry |
| Status | Terminated |
| Phase | Phase 2/Phase 3 |
| Study type | Interventional |
| Conditions | Nerve Compression Syndromes |
| Intervention type | Drug |
| Interventions | Erythropoietin infusion |
| Enrollment | 7 |
| Start date | Aug 1, 2005 |
| Primary completion | Jul 1, 2007 |
| Completion | Jul 1, 2007 |
| First posted | Sep 22, 2005 |
| Last update posted | May 22, 2008 |
| Countries | Canada |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: